CN103656131A

CN103656131A - Drug composition for treating cough

Info

Publication number: CN103656131A
Application number: CN201210317674.5A
Authority: CN
Inventors: 杨波
Original assignee: Individual
Current assignee: Individual
Priority date: 2012-08-31
Filing date: 2012-08-31
Publication date: 2014-03-26

Abstract

The invention discloses a drug composition for treating cough. The drug composition comprises 5-10 parts of tendril-leaved fritillary bulb, 10-50 parts of white mulberry root-bark, 20-50 parts of platycodon grandiflorum, 20-60 parts of loquat leaf, 20-30 parts of liquorice, 10-50 parts of dried orange peel and 10-20 parts of baical skullcap root. Compared with like drugs, the drug composition disclosed by the invention has the advantages of simple components and stable efficacy and is suitable for treating the cough, particularly the lung heat cough.

Description

A kind of pharmaceutical composition for coughing

Technical field

The present invention relates to a kind of pharmaceutical composition for coughing.

Background technology

Cough is a kind of protectiveness respiratory reflex action of human body.The generation of cough, is during due to sensor in foreign body, irritative gas, respiratory tract endocrine etc. stimulate respiratory mucosa, gets excited and passes to oblongata coughing centre by afferent nerve fiber, causes cough.The action of cough is very brief deeply air-breathing, and glottis closes, and respiratory muscle, Intercostal muscle and diaphram be fierce contraction fast, makes the gas of lung inner high voltage spouting, just becomes cough.Along with the air-flow of going out rapidly, foreign body or secretions in respiratory tract are excreted.

Theory of Chinese medical science thinks, cough is because of diseases caused by exogenous pathogenic factor six climate exopathogens, and internal organs internal injury affects the sound disease that has expectorant due to the lung.See that < < Plain Questions the five internal organs generate piece of writing > >.The < < Plain Questions pathogenesis gas collection > > that should save one's life: " cough meaning sound without expectorant, lung qi wound and also unclear; It is noiseless and have expectorant coughing, spleen wet moving and be expectorant also.Cough meaning has expectorant and sound, and it is wet that lid moves in spleen in lung qi due to wound, cough and for coughing also ".Because exopathogen is violated lung, or internal organs internal injury, involve due to the lung.

Summary of the invention

The object of this invention is to provide a kind of pharmaceutical composition for coughing, above-mentioned purpose is achieved by the following technical solution.

A pharmaceutical composition, is characterized in that the ingredients by following weight portion:

Bulbus Fritillariae Cirrhosae 5-10 part, Cortex Mori 10-50 part, Radix Platycodonis 20-50 part, Folium Eriobotryae 20-60 part, Radix Glycyrrhizae 20-30 part, Pericarpium Citri Reticulatae 10-50 part, Radix Scutellariae 10-20 part.

Bulbus Fritillariae Cirrhosae: cool in nature, sweet flat, enter lung meridian, stomach warp, there is nourishing the lung to arrest cough resolving phlegm and relieving asthma, the effect of removing heat-phlegm.

Cortex Mori: sweet cold, enter lung meridian, there is eliminating pathogen from the lung for relieving asthma, the effect of inducing diuresis to remove edema.For lung-heat cough with asthma, the edema of the face, the diseases such as dysuria.

Radix Platycodonis: return lung meridian, there is lung qi dispersing, eliminate the phlegm, sore-throat relieving, evacuation of pus, sharp the five internal organs, the effect that fills blood, mend five kinds of over strain, foster the spirit of nobility.Cure mainly cough with copious phlegm, laryngopharynx swelling and pain, lung abscess vomiting pus, fullness in the chest and hypochondriac pain, dysentery stomachache, aphtha of the mouth and tongue, conjunctival congestion and swelling pain, uroschesis.

Folium Eriobotryae: bitter, be slightly cold, attach to the lung and stomach meridians, there is clearing away lung-heat to relieve cough, the effect of stopping nausea and vomiting by lowering the adverse flow of QI.For cough due to lung-heat, QI rising in reverse order dyspnea with rapid respiration, gastropyretic vomiting, hiccup.

Radix Glycyrrhizae: property is flat, sweet in the mouth, returns 12 warps.Have removing toxic substances, eliminate the phlegm, pain relieving, spasmolytic be so that the pharmacological action such as anticancer.

Pericarpium Citri Reticulatae: warm in nature, acrid in the mouth, bitter in the mouth, enter spleen channel, stomach through, lung meridian, there is regulating qi-flowing for strengthening spleen, in tune, dampness, clears phlegm.Cure mainly the distension and fullness in the abdomen of stagnation of QI in spleen and stomach or pain, dyspepsia.Abdominal distention uncomfortable in chest, indigestion and loss of appetite loose stool in turbid damp resistance.Phlegm-damp is stopped up the cough and asthma of lung.

Radix Scutellariae: hardship, cold.Return lung, gallbladder, spleen, large intestine, small intestine meridian, there is heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive, the effect of blood pressure lowering.For hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, cough due to lung-heat, high hot excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus, frequent fetal movement.

As preferably, in the present invention, each ingredients weight parts is Bulbus Fritillariae Cirrhosae 5-8 part, Cortex Mori 30-50 part, Radix Platycodonis 30-50 part, Folium Eriobotryae 20-40 part, Radix Glycyrrhizae 20-25 part, Pericarpium Citri Reticulatae 25-50 part, Radix Scutellariae 10-15 part.

Further, 5 parts of the preferred Bulbus Fritillariae Cirrhosae of each component, 35 parts of Cortex Mori, 35 parts of Radix Platycodoniss, 40 parts of Folium Eriobotryaes, 25 parts, Radix Glycyrrhizae, 40 parts of Pericarpium Citri Reticulataes, 10 parts of Radix Scutellariaes in the present invention.

Or 8 parts of preferred Bulbus Fritillariae Cirrhosae, 50 parts of Cortex Mori, 50 parts of Radix Platycodoniss, 30 parts of Folium Eriobotryaes, 25 parts, Radix Glycyrrhizae, 50 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scutellariaes.

Also or preferably 10 parts of Bulbus Fritillariae Cirrhosae, 40 parts of Cortex Mori, 45 parts of Radix Platycodoniss, 35 parts of Folium Eriobotryaes, 20 parts, Radix Glycyrrhizae, 50 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scutellariaes.

After pharmaceutical composition of the present invention only need mix medicine in use by weight, after boiled water decocts, filtering residue is taken.

Pharmaceutical composition of the present invention is compared with similar drugs, has component simple, and efficacy stability is applicable to cough, the especially treatment of lung heat cough.

The specific embodiment

Embodiment 1

For cough medicine compositions, by following drug component, formed: 5 parts of Bulbus Fritillariae Cirrhosae, 35 parts of Cortex Mori, 35 parts of Radix Platycodoniss, 40 parts of Folium Eriobotryaes, 25 parts, Radix Glycyrrhizae, 40 parts of Pericarpium Citri Reticulataes, 10 parts of Radix Scutellariaes.

Embodiment 2

For cough medicine compositions, by following drug component, formed: 8 parts of Bulbus Fritillariae Cirrhosae, 50 parts of Cortex Mori, 50 parts of Radix Platycodoniss, 30 parts of Folium Eriobotryaes, 25 parts, Radix Glycyrrhizae, 50 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scutellariaes.

Embodiment 3

For cough medicine compositions, by following drug component, formed: 10 parts of Bulbus Fritillariae Cirrhosae, 40 parts of Cortex Mori, 45 parts of Radix Platycodoniss, 35 parts of Folium Eriobotryaes, 20 parts, Radix Glycyrrhizae, 50 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scutellariaes.

Embodiment 4

Pharmaceutical composition clinical observation on the therapeutic effect experiment of the present invention

Adopt Chinese medicine composition of the present invention to treat altogether 50 routine patients, male 28 examples wherein, female's 22 examples; Age interval is at 15-67 between year.Patient is divided into two groups, 25 every group.Respectively impose pharmaceutical composition described in embodiment 1-3 3 days, observe the curative effect.Wherein, the standard of curative effect evaluation is:

Cure: five coughs only, are breathed smooth and easyly, and sign and symptom are improved completely.

Effective: cough is even to be had, and respiratory quotient is more smooth and easy, and sign and symptom change.

Invalid: sign is without change, and symptom is as front.

Cure 17 examples for first group, effective 5 examples, invalid 3 examples, cure 18 examples for second group, effective 6 examples, invalid 1 example.Pharmaceutical composition effective percentage of the present invention reaches 92%.

Claims

1. a pharmaceutical composition, is characterized in that the ingredients by following weight portion: Bulbus Fritillariae Cirrhosae 5-10 part, Cortex Mori 10-50 part, Radix Platycodonis 20-50 part, Folium Eriobotryae 20-60 part, Radix Glycyrrhizae 20-30 part, Pericarpium Citri Reticulatae 10-50 part, Radix Scutellariae 10-20 part.

2. pharmaceutical composition as claimed in claim 1, is characterized in that the ingredients by following weight portion: Bulbus Fritillariae Cirrhosae 5-8 part, Cortex Mori 30-50 part, Radix Platycodonis 30-50 part, Folium Eriobotryae 20-40 part, Radix Glycyrrhizae 20-25 part, Pericarpium Citri Reticulatae 25-50 part, Radix Scutellariae 10-15 part.

3. pharmaceutical composition as claimed in claim 1, is characterized in that the ingredients by following weight portion: 5 parts of Bulbus Fritillariae Cirrhosae, 35 parts of Cortex Mori, 35 parts of Radix Platycodoniss, 40 parts of Folium Eriobotryaes, 25 parts, Radix Glycyrrhizae, 40 parts of Pericarpium Citri Reticulataes, 10 parts of Radix Scutellariaes.

4. pharmaceutical composition as claimed in claim 1, is characterized in that the ingredients by following weight portion: 8 parts of Bulbus Fritillariae Cirrhosae, 50 parts of Cortex Mori, 50 parts of Radix Platycodoniss, 30 parts of Folium Eriobotryaes, 25 parts, Radix Glycyrrhizae, 50 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scutellariaes.

5. pharmaceutical composition as claimed in claim 1, is characterized in that the ingredients by following weight portion: 10 parts of Bulbus Fritillariae Cirrhosae, 40 parts of Cortex Mori, 45 parts of Radix Platycodoniss, 35 parts of Folium Eriobotryaes, 20 parts, Radix Glycyrrhizae, 50 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Scutellariaes.

6. the purposes in the medicine that the pharmaceutical composition described in claim 1-5 any one is coughed in preparation treatment.